IMM 1.18% 43.0¢ immutep limited

Media, page-13

  1. 5,240 Posts.
    lightbulb Created with Sketch. 1641
    On Aug 24th they they changed the completion date from Aug 10 to Aug 31 ... so, they may have been anticipating the patent approval. It may be obvious to some but one may still ask the question, if this postponement of completion (by weeks, days) is related to the anticipation of patent approval (?)

    Here are some dates and patients anticipated at the time ...

    Jan 2018, 126(anticipated)
    July 2018, 96(anticipated)
    June 2019, 84(anticipated)
    Jan 2020, 88(Actual - Stopped recruiting - likely due to covid (?) )
    Study completion date has been pushed back a number of times from initial Oct 2020 to Aug 2021. This is likely a good thing - because it means the study was continuing and no serious adverse effect was observed or significant to report which in trials terms is good news meaning those who are surviving are doing ok .... perhaps. I hope! So, it is all about numbers when they come out and I have a feeling they will be out soon-ish ... perhaps. I hope!

    For those who are not familiar with trials: recruitment usually finishes quite some time before the completion of study. This is to allow following up on the last patient recruited for a set period of time. For this trial: 24 months (primary outcome) and 3 years (for secondary outcome).



 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
43.0¢
Change
0.005(1.18%)
Mkt cap ! $511.1M
Open High Low Value Volume
42.5¢ 43.0¢ 41.5¢ $2.818M 6.626M

Buyers (Bids)

No. Vol. Price($)
6 168332 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 129388 6
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
43.0¢
  Change
0.005 ( 0.51 %)
Open High Low Volume
42.5¢ 43.0¢ 41.5¢ 818937
Last updated 15.59pm 07/06/2024 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.